Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis
Published in Journal of Experimental Medicine, 2024
First-author dissertation work showing that the gut microbiota of patients who develop immune checkpoint inhibitor-related colitis is colitogenic at baseline, before therapy begins.
Recommended citation: Shang, J., Del Valle, D. M., Britton, G. J., Mead, K. R., Rajpal, U., Chen-Liaw, A., Mogno, I., Li, Z., Menon, R., Gonzalez-Kozlova, E., Elkrief, A., Peled, J. U., Gonsalves, T. R., Shah, N. J., Postow, M., Colombel, J.-F., Gnjatic, S., Faleck, D. M., & Faith, J. J. (2024). "Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis." Journal of Experimental Medicine, 222(1), e20232079.
Download Paper
